
HUVY is a medtech startup, created in 2021, that helps detect skin cancers using AI.
Founded: 2021
Product: AI clinical decision support for melanoma detection (CE Class IIb)
Regulatory: CE Class IIb (EU MDR)
Tech / Data: Trained on >100,000 cases; validated in multiple clinical studies (~3,000+ patients)
Location / Size: France; ~14 employees
Dermatology — early detection and triage of melanoma
2021
Hospitals and Health Care
“Public profiles list investors including Charente family holding and Bpifrance Digital Venture; seed-stage reported in some company profiles.”
| Company |
|---|